Delivery Order SPE2DX15D3005-SPE2DX24F3STD
Award Date
7/12/24
Potential Completion Date
7/15/24
Potential Value
$31K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,230.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of Prolia 60 mg/ml syringes, a specialty pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,525.12 firm fixed-price delivery order is for the supply of Prolia 60 mg/mL syringes. The contract has an ultimate completion date of May 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, with a ceiling value of $3,572.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Prolia 60 mg/ml syringes, a pharmaceutical product, and is a Firm Fixed Price Delivery Order with a performance period ending on May 7, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,648.20 firm fixed-price delivery order is for the pharmaceutical product Prolia 60 mg/mL Syringe. The contract has a completion date of February 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,184.26 Delivery Order is for the pharmaceutical product Prolia 60 mg/mL syringe. The contract has a Firm Fixed Price pricing type and a completion date of July 16, 2024. It is not associated with a set-aside designation. AmerisourceBergen, one of the largest pharmaceutical distribution companies, holds a substantial Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,260.68 firm fixed-price delivery order is for the supply of Prolia 60 mg/mL syringes. The award has an ultimate completion date of September 27, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,907.80, is for the delivery of Prolia 60 mg/ml syringes. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 29, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Prolia 60 mg/ml syringes to the Defense Logistics Agency (DLA). The contract has a ceiling value of $20,921.04 and a period of performance through May 2, 2024. It is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,428.70, is for the delivery of Prolia 60 mg/ml syringes. It is a firm fixed-price delivery order contract with an ultimate completion date of April 3, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,743.42 firm-fixed-price delivery order is for the supply of Prolia 60 mg/mL syringes, with a period of performance through September 2024. Amerisourcebergen is delivering these pharmaceutical products under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC...